According to a market report by Lucintel, the future of the global dG(ibu) Phosphoramidite market looks promising with opportunities in the biotechnology company and research laboratory markets. The global dG(ibu) Phosphoramidite market is expected to grow with a CAGR of 8% from 2025 to 2031. The major drivers for this market are the rising demand for rna therapeutics, the increasing focus on gene editing, and the growing applications in oligonucleotide synthesis.
A more
than 150-page report to understand trends, opportunity and forecast in global dG(ibu)
Phosphoramidite market to 2031 by type (purity ≥98%, purity ≥99%, and others),
application (biotechnology companies and research laboratories), and region
(North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel
forecasts that, within the type category, purity ≥99% is expected to witness
higher growth over the forecast period.
Within the
application category, biotechnology company is expected to witness higher
growth.
Download
sample by clicking on dG(ibu)
Phosphoramidite market.
In terms
of region, APAC is expected to witness the highest growth over the forecast
period.
Glen
Research, ChemGenes, Bioneer, Thermo Fisher Scientific, Merck, BOC Sciences,
TCI, Hongene Biotech, Biosynth Carbosynth, BLD Pharmatech are the major
suppliers in the dG(ibu)
Phosphoramidite market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Patient Repositioning Offloading Device Market
No comments:
Post a Comment